Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Recombinant Zoster Vaccine in Stable SLE Patients(Vtrial)

NCT04516408 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04516408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Recombinant Zoster Vaccine in Stable SLE Patients(Vtrial)
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 20, 2021
Completion date
September 30, 2023
Enrollment
464 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, recombinant zoster vaccine, systemic lupus erythematosus